- Home
- MLAB vs HQL Comparison
MLAB vs HQL Comparison
Compare MLAB & HQL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MLAB | HQL |
|---|---|---|
| Founded | 1982 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Investment Managers |
| Sector | Industrials | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 489.8M | 496.4M |
| IPO Year | 1995 | N/A |
Fundamental Metrics
Financial Performance| Metric | MLAB | HQL |
|---|---|---|
| Price | $96.27 | $16.65 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $94.00 | N/A |
| AVG Volume (30 Days) | 70.4K | ★ 126.2K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | 0.67% | ★ 11.56% |
| EPS Growth | ★ 99.24 | N/A |
| EPS | ★ 1.95 | 0.79 |
| Revenue | N/A | N/A |
| Revenue This Year | $6.07 | N/A |
| Revenue Next Year | $5.41 | N/A |
| P/E Ratio | $48.76 | ★ $21.06 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $59.63 | $10.55 |
| 52 Week High | $142.19 | $17.80 |
Technical Indicators
Market Signals| Indicator | MLAB | HQL |
|---|---|---|
| Relative Strength Index (RSI) | 64.97 | 42.46 |
| Support Level | $91.62 | $16.40 |
| Resistance Level | $98.14 | $17.46 |
| Average True Range (ATR) | 4.10 | 0.25 |
| MACD | 0.35 | -0.05 |
| Stochastic Oscillator | 94.86 | 17.54 |
Price Performance
Historical ComparisonAbout MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About HQL abrdn Life Sciences Investors Shares of Beneficial Interest
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing mainly in securities of life sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser to have the potential for above-average growth.